www.amex.com |
| Equity Release |
Media Contact: Catherine Chantharaj |
AMERICAN STOCK EXCHANGE LISTS COMMON STOCK OF CHINA SHENGHUO PHARMACEUTICALS HOLDINGS, INC. | ||
New York, June 14, 2007 — The American Stock Exchange® (Amex®) today listed the common stock of China Shenghuo Pharmaceuticals Holdings, Inc. under the ticker symbol KUN. China Shenghuo Pharmaceuticals Holdings, Inc. engages in the research, development, manufacture, and marketing of pharmaceutical, nutritional supplement and cosmetic products. Almost all of the products are derived from the medicinal herb Panax notoginseng, also known as Sanqi, Sanchi or Tienchi. "We are pleased to welcome China Shenghuo Pharmaceuticals Holdings to the American Stock Exchange," said John McGonegal, Senior Vice President Amex Equities Group. "An IPO is a great milestone for any company and we look forward to supporting Shenghuo Pharmaceuticals as it seeks to convey its value proposition to a greater number of investors." Mr. Gui Hua Lan, Chairman and CEO of China Shenghuo, said, “Listing on a well-respected, senior exchange such as the American Stock Exchange marks an important milestone in our drive to enhance investor awareness and increase shareholder value." The specialist in China Shenghuo Pharmaceuticals Holdings, Inc. will be Kellogg Capital Group LLC. For further information on KUN and other Amex-listed companies, please visit www.amex.com. | ||
About American Stock Exchange
The American Stock Exchange® (Amex®) offers trading across a full range of equities, options and exchange traded funds (ETFs), including structured products and HOLDRSSM. In addition to its role as a national equities market, the Amex is the pioneer of the ETF, responsible for bringing the first domestic product to market in 1993. Leading the industry in ETF listings, the Amex lists 320 ETFs to date. The Amex is also one of the largest options exchanges in the U.S., trading options on broad-based and sector indexes as well as domestic and foreign stocks.